EpicGenetics, Inc. is a state-of-the-art medical testing laboratory service that provides tests for diagnosis, screening or evaluation of diseases and health conditions, including fibromyalgia.
The Centers for Medicare & Medicaid Services (CMS) regulates all laboratory testing (except research) performed on humans in the U.S. through the Clinical Laboratory Improvement Amendments (CLIA). In total, CLIA covers approximately 254,000 laboratory entities, including EpicGenetics, which is certified under the federal program, and operates in compliance with all governmental regulations.
Using the latest diagnostic technology, EpicGenetics has also been awarded an accreditation by the Commission on Laboratory Accreditation of the College of American Pathologists (CAP), based on the results of their stringent, on-site inspections. The College of American Pathologists is a medical society serving nearly 16,000 physician members and the laboratory community throughout the world. It is the world’s largest association composed exclusively of pathologists and is widely considered the leader in laboratory quality assurance. The CAP is an advocate for high-quality and cost-effective medical care.
During the CAP accreditation process, inspectors examine the laboratory’s records and quality control of procedures for the preceding two years. CAP inspectors also examine the entire staff’s qualifications, the laboratory’s equipment, facilities, safety program and record, as well as the overall management of the laboratory. This stringent inspection program is designed to specifically ensure the highest standard of care for the laboratory’s patients.
Out of the more than 245,000 laboratory entities falling under the regulatory framework of the federal CLIA program, fewer than 3% meet the standards of excellence needed to achieve CAP-accreditation. EpicGenetics is proud to be CAP-accredited. We are one of fewer than 7,000 laboratories worldwide to possess this very important accreditation.